Clinical Trial Update: A Phase Ib Trial of Combined Febuxostat and Inosine Therapy in Patients With Parkinson's Disease [Phase 1]

View source ↗

Summary

A Phase Ib clinical trial evaluating combined febuxostat and inosine therapy for Parkinson's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• FEBUXOSTAT (Febuxostat)
• Inosine (inosine)

Snippet

Sponsor: Fujita Health University | Conditions: Parkinson's Disease (PD) | Phase 1 | Status: RECRUITING